Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$32.16+2.64 (+8.94%)
Close on Nov 18, 2026Market cap $1.21BP/E –Yield –
Harrow revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Harrow's revenue for the twelve months ending Jun 30, 2026 was $275.59M, up 21.1% year over year. For fiscal 2025 it was $272.30M, up 36.4% from the year before. Over ten years it grew 39.6% a year on average. The highest annual figure on record is $272.30M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $272.30M | +36.4% |
| FY2024 | Dec 31, 2024 | $199.61M | +53.3% |
| FY2023 | Dec 31, 2023 | $130.19M | +47.0% |
| FY2022 | Dec 31, 2022 | $88.60M | +22.2% |
| FY2021 | Dec 31, 2021 | $72.48M | +48.3% |
| FY2020 | Dec 31, 2020 | $48.87M | -4.5% |
| FY2019 | Dec 31, 2019 | $51.17M | +23.7% |
| FY2018 | Dec 31, 2018 | $41.37M | +54.5% |
| FY2017 | Dec 31, 2017 | $26.77M | +34.3% |
| FY2016 | Dec 31, 2016 | $19.94M | +105.2% |
| FY2015 | Dec 31, 2015 | $9.72M | +485.3% |
| FY2014 | Dec 31, 2014 | $1.66M | +16500.0% |
| FY2013 | Dec 31, 2013 | $10.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $70.66M | +10.9% |
| Q1 FY2026 | Mar 31, 2026 | $44.20M | -7.6% |
| Q4 FY2025 | Dec 31, 2025 | $89.09M | +33.3% |
| Q3 FY2025 | Sep 30, 2025 | $71.64M | +45.4% |
| Q2 FY2025 | Jun 30, 2025 | $63.74M | +30.2% |
| Q1 FY2025 | Mar 31, 2025 | $47.83M | +38.3% |
| Q4 FY2024 | Dec 31, 2024 | $66.83M | +83.8% |
| Q3 FY2024 | Sep 30, 2024 | $49.26M | +43.8% |
| Q2 FY2024 | Jun 30, 2024 | $48.94M | +46.2% |
| Q1 FY2024 | Mar 31, 2024 | $34.59M | +32.5% |
| Q4 FY2023 | Dec 31, 2023 | $36.36M | +78.8% |
| Q3 FY2023 | Sep 30, 2023 | $34.27M | +50.1% |
| Q2 FY2023 | Jun 30, 2023 | $33.47M | +43.5% |
| Q1 FY2023 | Mar 31, 2023 | $26.10M | +18.0% |
| Q4 FY2022 | Dec 31, 2022 | $20.33M | +0.7% |
| Q3 FY2022 | Sep 30, 2022 | $22.82M | +22.0% |
| Q2 FY2022 | Jun 30, 2022 | $23.32M | +28.6% |
| Q1 FY2022 | Mar 31, 2022 | $22.12M | +43.2% |
| Q4 FY2021 | Dec 31, 2021 | $20.19M | +38.3% |
| Q3 FY2021 | Sep 30, 2021 | $18.71M | +29.9% |
| Q2 FY2021 | Jun 30, 2021 | $18.13M | +125.0% |
| Q1 FY2021 | Mar 31, 2021 | $15.44M | +30.7% |
| Q4 FY2020 | Dec 31, 2020 | $14.60M | +15.8% |
| Q3 FY2020 | Sep 30, 2020 | $14.40M | +12.9% |
| Q2 FY2020 | Jun 30, 2020 | $8.06M | -40.4% |
| Q1 FY2020 | Mar 31, 2020 | $11.82M | -3.8% |
| Q4 FY2019 | Dec 31, 2019 | $12.60M | +10.7% |
| Q3 FY2019 | Sep 30, 2019 | $12.76M | +18.8% |
| Q2 FY2019 | Jun 30, 2019 | $13.52M | +30.2% |
| Q1 FY2019 | Mar 31, 2019 | $12.29M | +38.6% |
| Q4 FY2018 | Dec 31, 2018 | $11.38M | +55.2% |
| Q3 FY2018 | Sep 30, 2018 | $10.74M | +65.6% |
| Q2 FY2018 | Jun 30, 2018 | $10.38M | +51.4% |
| Q1 FY2018 | Mar 31, 2018 | $8.87M | +45.4% |
| Q4 FY2017 | Dec 31, 2017 | $7.34M | +26.7% |
| Q3 FY2017 | Sep 30, 2017 | $6.48M | +33.4% |
| Q2 FY2017 | Jun 30, 2017 | $6.86M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.10M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.79M | – |
| Q3 FY2016 | Sep 30, 2016 | $4.86M | – |
See a number that looks wrong?